Organization
Immunobiological Technology Institute / Oswaldo Cruz Foundation
4 clinical trials
Clinical trial
Yellow Fever Vaccine Immunity After 1 Dose of Vaccine in Children and Adults: a Cohort Study in Non-endemic AreaStatus: Active (not recruiting), Estimated PCD: 2026-06-01
Clinical trial
Efficacy and Safety Evaluation of the Intralesional Recombinant Human Epidermal Growth Factor (rhEGF) in Subjects With Diabetic Foot Ulcer. Multicenter, Randomized, Double-blind, Placebo-controlled Study.Status: Active (not recruiting), Estimated PCD: 2019-12-01
Clinical trial
A Phase 1b / 2a, Double-Blind, Randomized, Placebo-Controlled, Antigen Dose-Escalation Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of LEP-F1 + GLA-SE in Adult Participants in Areas Endemic for LeprosyStatus: Not yet recruiting, Estimated PCD: 2024-03-01
Clinical trial
Immunogenicity Study of the Covid-19 (Recombinante) Vaccine - Fiocruz/AstraZeneca When Administered With a 4 or 8 Weeks Interval Between the First Two Doses.Status: Active (not recruiting), Estimated PCD: 2022-03-31